Development of a Multiparametric Magnetic Resonance Imaging-Based Nomogram for Clinically Insignificant Prostate Cancer
The Korean Journal of Urological Oncology. 2020;18(3):222-229 
Editorial for “Biparametric Magnetic Resonance Imaging‐Derived Nomogram to Detect Clinically Significant Prostate Cancer by Targeted Biopsy for Index Lesion”
Journal of Magnetic Resonance Imaging. 2021;56(2):425-426
Biparametric Magnetic Resonance Imaging‐Derived Nomogram to Detect Clinically Significant Prostate Cancer by Targeted Biopsy for Index Lesion
Journal of Magnetic Resonance Imaging. 2021;55(4):1226-1233
Development of a nomogram combining multiparametric magnetic resonance imaging and PSA‐related parameters to enhance the detection of clinically significant cancer across different region
The Prostate. 2022;82(5):556-565
MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
BioMed Research International. 2018;2018:1-10
Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer
Indian Journal of Radiology and Imaging. 2021;
Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI‐RADS v2
Journal of Magnetic Resonance Imaging. 2017;47(4):1072-1079
Re: Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
European Urology. 2015;68(4):738
Comparison of Multiparametric and Fast
MRI
Protocols in Detecting Clinically Significant Prostate Cancer and a Detailed Cost Analysis
Journal of Magnetic Resonance Imaging. 2022;
Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer
BJU International. 2018;122(6):1025-1033